Divi's Labs Q3 net up 12% to Rs 247 crore

Revenues up 8% at Rs 853 cr; Forex gain for current quarter at Rs 3 cr, versus Rs 11 cr a year ago

Hyderabad-based pharmaceutical company, Divi's Laboratories Limited, has reported a 11.76 per cent increase in its net profit to Rs 246.53 crore for the third quarter ended December 2015, as against Rs 220.58 crore in the corresponding quarter last year.

The company's revenues rose 7.8 per cent to Rs 852.87 crore during the quarter under review, as against Rs 791.12 crore in the corresponding previous quarter.

Forex gain for the current quarter amounted to Rs 3 crore, as against a forex gain of Rs 11 crore during the same period a year ago. The company has capitalised fixed assets aggregating Rs 34 crore during the third quarter, Divi's said in a filing to the exchanges.

Divi's Laboratories Limited's scrip ended the day at Rs 1,104.15 on the BSE on Friday, up 1.43 per cent, over the previous close of Rs 1,088.55.